Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis
Science Immunology · 19.04.2024 · 9 (94)
DOI: 10.1126/sciimmunol.adg7549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 19.04.2024. Verfasst von Pablo Canales-Herrerias und 44 weiteren Autor:innen. Beteiligte Einrichtung: Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Vedolizumab (VDZ) is a first-line treatment in ulcerative colitis (UC) that targets the α4β7- mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1) axis. To determine the mechanisms of action of VDZ, we examined five distinct cohorts of patients with UC. A decrease in naïve B and T cells in the intestines and gut-homing (β7 + ) plasmablasts in circulation of VDZ-treated patients suggested that VDZ targets gut-associated lymphoid tissue (GALT). Anti-α4β7 blockade in wild-type and photoconvertible (KikGR) mice confirmed a loss of GALT size and cellularity because of impaired cellular entry. In VDZ-treated patients with UC, treatment responders demonstrated reduced intestinal lymphoid aggregate size and follicle organization and a reduction of β7 + IgG + plasmablasts in circulation, as well as IgG + plasma cells and FcγR-dependent signaling in the intestine. GALT targeting represents a previously unappreciated mechanism of action of α4β7-targeted therapies, with major implications for this therapeutic paradigm in UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Gastroenterology Department, Fédération Hospitalo-Universitaire TRUE (InnovaTive theRapy for immUne disordErs), Cr…
- Department of Pathology, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
- Translational Research in Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
ORCID-Profile: Pablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, Rafael S Czepielewski, Bram Verstockt, Alexandra E Livanos, Fiona Raso, Daniel Dai, Andrew Wang, Zainab Al-Taie, Huaibin M Ko, Minami Tokuyama, Hadar Meringer, Francesca Cossarini, Divya Jha, Azra Krek, John D Paulsen, Mohammad Zuber Nakadar, Emma C Erlich, Emily J Onufer, Beth A Helmink, Grace Chung, Travis Dawson, Vijay Yajnik, Andrea Cerutti, Jeremiah J Faith, Gwendalyn J Randolph, Alexandros D Polydorides, Andrea Reboldi, Jean-Frederic Colombel, Saurabh Mehandru
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Canales-Herrerias, P., Uzzan, M., Seki, A., Czepielewski, R. S., Verstockt, B., Livanos, A. E., Raso, F., Dunn, A., Dai, D., Wang, A., Al-Taie, Z., Martin, J., Laurent, T., Ko, H. M., Tokuyama, M., Tankelevich, M., Meringer, H., Cossarini, F., Jha, D., …, & Mehandru, S. (2024). Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis. Science Immunology, 9(94). https://doi.org/10.1126/sciimmunol.adg7549
Vancouver
Canales-Herrerias P, Uzzan M, Seki A, Czepielewski RS, Verstockt B, Livanos AE, et al. Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis. Science Immunology. 2024;9(94). doi:10.1126/sciimmunol.adg7549
BibTeX
@article{CanalesHerrerias2024,
author = {Canales-Herrerias, Pablo and Uzzan, Mathieu and Seki, Akihiro and Czepielewski, Rafael S and Verstockt, Bram and Livanos, Alexandra E and Raso, Fiona and Dunn, Alexandra and Dai, Daniel and Wang, Andrew and Al-Taie, Zainab and Martin, Jerome and Laurent, Thomas and Ko, Huaibin M and Tokuyama, Minami and Tankelevich, Michael and Meringer, Hadar and Cossarini, Francesca and Jha, Divya and Krek, Azra and Paulsen, John D and Taylor, Matthew D and Nakadar, Mohammad Zuber and Wong, Joshua and Erlich, Emma C and Mintz, Rachel L and Onufer, Emily J and Helmink, Beth A and Sharma, Keshav and Rosenstein, Adam and Ganjian, Danielle and Chung, Grace and Dawson, Travis and Juarez, Julius and Yajnik, Vijay and Cerutti, Andrea and Faith, Jeremiah J and Suarez-Farinas, Mayte and Argmann, Carmen and Petralia, Francesca and Randolph, Gwendalyn J and Polydorides, Alexandros D and Reboldi, Andrea and Colombel, Jean-Frederic and Mehandru, Saurabh},
title = {Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {94},
doi = {10.1126/sciimmunol.adg7549}
}
EUVIMED